PROTAC SOS1 degrader-1

PROTAC SOS1degrader-1 是一种有效的 PROTAC SOS1 降解剂(DC50 为 98.4 nM),在多种 KRAS 突变的癌细胞中显示出抗增殖活性,具有抗肿瘤作用且毒性低(粉色:SOS1 配体 (MS-Y58460);蓝色:VHL 配体 (MS-R95960);黑色:连接子)。
产品编号: MS-D17610 CAS No.: 2913185-35-8 分子式: C57H76ClFN10O4S 分子量: 1051.79
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
询价

产品描述

PROTAC SOS1degrader-1 是一种有效的 PROTAC SOS1 降解剂(DC50 为 98.4 nM),在多种 KRAS 突变的癌细胞中显示出抗增殖活性,具有抗肿瘤作用且毒性低(粉色:SOS1 配体 (MS-Y58460);蓝色:VHL 配体 (MS-R95960);黑色:连接子)。

生物实验数据

生物活性 PROTAC SOS1degrader-1 is a potent PROTAC SOS1 degrader with a DC50 of 98.4 nM that exhibits antiproliferative activity in various KRAS-mutant cancer cells and exerts antitumor effects with low toxicity (pink: SOS1 ligand (MS-Y58460); blue: VHL ligand (MS-R95960); black: linker).
IC50 & Target

DC50: 98.4 nM (SOS1)

体外研究
(In Vitro)

PROTAC SOS1 degrader-1 (compound 9d) (0.1, 1 μM) shows SOSI degradation activity with an SOS1 protein degradation of 56.2 and 92.5% at 0.1 and 1 μM, respectively.
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) exhibits SOS1 degradation activity with an DC50 of 98.4 nM in a dose- and time-dependent manner in NCI-H358 cells.
PROTAC SOS1 degrader-1 (0-2500 nM; 24 h) dose-dependently reduced the SOS1 protein level but showed no effect on SOS2 and KRAS up to 2.5 μM in NCI-H358 and AsPc-1 cells.
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) reduces the expression of KRAS-GTP, induced ERK phosphorylation with an IC50value of 72.3 nM, and significantly increases the pERK level after 6-24 h.

Western Blot Analysis

Cell Line: NCI-H358 cells
Concentration: 0-2000 nM
Incubation Time: 0-24 h
Result: Decreased the expression of SOS1 in a dose- and time-dependent manner in NCI-H358 cells.

RT-PCR

Cell Line: NCI-H358 cells
Concentration: 1 µM
Incubation Time: 24, 48, 72 h
Result: Showed no effffect on SOS2 mRNA expression.

Cell Proliferation Assay

Cell Line: NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration: 0-10000 nM
Incubation Time: 7 days
Result: Showed anti-proliferation activity with an IC50s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM and DC50s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM for NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.
体内研究
(In Vivo)

PROTAC SOS1 degrader-1 (10 mg/kg; i.p.) shows good PK profile with low toxicity.
PROTAC SOS1 degrader-1 (0, 10, 20 mg/kg; i.p.; once a day for 3 weeks) shows significant anti-tumor activities in the xenograft mouse model.
Pharmacokinetic Parameters of PROTAC SOS1 degrader-1 in BALB/c mice.

compound dose (mg/kg) T1/2 (h) Tmax (h) Cmax (ng/mL) AUClast (h*ng/mL) AUCINF (h*ng/mL) MRTINF-obs(h)
9d 10 8.64±0.31 0.250v±0 1221±132 3895±335 4420±363 10.2±0.4
Male BALB/c mice; 10 mg/kg for i.p..

Animal Model: Male BALB/c mice
Dosage: 10 mg/kg (dissolved in solution containing dimethyl sulfoxide, PEG400, and 10% hydroxypropyl-β-cyclodextrin in water (5/5/90, v/v/v))
Administration: I.p.
Result: Showed good PK profile with high exposure (AUC0‑∞ = 4420 h*ng/mL) and maximum concentration (Cmax = 1221 ng/mL) in mouse plasma.
Animal Model: 6-8 weeks, BALB/c mice
Dosage: 0, 10, 20 mg/kg
Administration: I.p.; once a day for a week
Result: Showed low toxicity for mouse.
Animal Model: 6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts)
Dosage: 0, 10, 20 mg/kg
Administration: I.p.; once a day for 3 weeks;
Result: Inhibited the tumor growth by 72.5 and 86.1% at 10 and 20 mg/kg, respectively.
Animal Model: 6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts)
Dosage: 0, 20, 50 mg/kg
Administration: Intratumoral injection; twice-weekly for 5 weeks
Result: Significantly prevented tumor growth in vivo with a good safety profile.

化学信息

分子量 1051.79
分子式 C57H76ClFN10O4S
CAS No. 2913185-35-8

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础